diabetic retinopathy glp 1 Glucagon-like peptide-1 receptor agonists rescued vascular endothelial damage through suppression of aberrant STING signaling The GLP-1RA/GIP agonist tirzepatide increased

From diabetes to oncology: glucagon-like peptide-1 (GLP-1) receptor agonists dual role in prostate cancer

Depending on your dosage, you might not use up the whole pen by the expiration date (and thus would be wasting leftover medication)

GLP1 RAs may exert direct kidney benefits through nonglycaemic mechanisms, including antiinflammatory, antioxidative and immunomodulatory effects

A large proportion of these studies reported on the impact of GLP-1RAs on dopaminergic neurotransmission responsible for reward processingwhich could contribute to their efficacy as anti-obesity medications by means of a reduction of food-related incentive 110

[DOI] [PubMed] [Google Scholar] 54.Dupre J, Ross SA, Watson D, Brown JC